Effects of a Leukemia-associated Gain-of-Function Mutation of SHP-2 Phosphatase on Interleukin-3 Signaling
Open Access
- 1 March 2006
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 281 (9), 5426-5434
- https://doi.org/10.1074/jbc.m507622200
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survivalOncogene, 2004
- Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signalingOncogene, 2003
- The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signalingTrends in Biochemical Sciences, 2003
- Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressorGenes & Development, 2003
- IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiledOncogene, 2000
- Shc associates with the IL-3 receptor β subunit, SHIP and Gab2 following IL-3 stimulation: Contribution of Shc PTB and SH2 domainsCellular Signalling, 2000
- Signaling Domains of the betac Chain of the GM-CSF/IL-3/IL-5 ReceptorAnnals of the New York Academy of Sciences, 1999
- A Deletion Mutation in the SH2-N Domain of Shp-2 Severely Suppresses Hematopoietic Cell DevelopmentMolecular and Cellular Biology, 1997
- Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapyMolecular Medicine Today, 1996
- Evidence for a Physical Association between the Shc-PTB Domain and the βc Chain of the Granulocyte-Macrophage Colony-stimulating Factor ReceptorPublished by Elsevier BV ,1996